Envista Holdings (NVST) Raw Materials (2018 - 2019)
Envista Holdings (NVST) posted Raw Materials of $70.2 million for Q3 2019, down 9.54% on a QoQ basis from $77.6 million in Q4 2018.
Analysis
Envista Holdings (NVST) Raw Materials (2018 - 2019) Analysis & Trends
Envista Holdings has reported Raw Materials for 2 years, with the latest figure at $70.2 million in Q3 2019.
- On a quarterly basis, Raw Materials changed N/A year-over-year to $70.2 million in Q3 2019; TTM through Sep 2019 was $70.2 million, a N/A change from a year earlier, with the FY2018 full-year figure at $77.6 million, changed N/A from the prior year.
- Raw Materials was $70.2 million for Q3 2019 at Envista Holdings, down from $77.6 million in the prior quarter.
- The five-year high for Raw Materials was $77.6 million in Q4 2018, with the low at $70.2 million in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn |